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Abstract
Autoimmune bullous diseases are heterogeneous group of disorders characterized by 
intraepidermal and subepidermal bullae formation. Autoantibodies to major players of 
skin integrity cause devastating symptoms in autoimmune bullous diseases that may 
result with morbidity and even mortality in the affected patients. These group of diseases 
can be categorized by the level of splitting in the skin and by structural proteins that are 
targeted by autoantibodies. Autoimmune bullous diseases can be divided into four basic 
subgroups: pemphigus, pemphigoid, epidermolysis bullosa acquisita and dermatitis her-
petiformis, although their different subtypes have been defined. In this chapter, the struc-
ture and tasks of desmosomes and basement membrane zone, which consist of the major 
antigens of the skin integrity targeted by autoantibodies, are examined, and the relation 
of target antigens and autoimmune bullous diseases is discussed.
Keywords: autoimmune bullous disease, autoantibodies, desmosomes, acantholysis, 
basement membrane zone
1. Introduction
Bullae are formed as a result of the damage of skin integrity due to various reasons, including 
bacterial or viral infections, trauma, genetic disorders and autoantibodies and fluid accumu-
lation in the different layers of the skin; subcorneal, suprabasilar, dermal-epidermal junction 
and upper dermis [1]. Autoimmune bullous diseases (ABD) are a heterogeneous group of 
rare but fatal or debilitating skin diseases characterized by varying degrees of mucosal and 
cutaneous blister formation due to autoantibodies directed against the structural proteins of 
epidermis or the dermal-epidermal junction [2, 3]. ABD are classified according to the loca-
tion of the bullae in the skin and the antigens targeted by the antibodies. They are simply 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
examined in four main groups: pemphigus, pemphigoid, acquired epidermolysis bullosa and 
dermatitis herpetiformis [1].
It is important to know the structure of the skin and antigens targeted by autoantibodies 
in order to better understand the ABD. The epidermal stratified squamous epithelium is a 
complex structure which includes several layers of keratinocytes. Cohesion among these 
cells is needed to preserve the epidermal architecture and function [4]. Epidermal integrity 
is provided by three types of junctional structures: (1) anchoring junctions (desmosomes and 
adherens junctions), major adhesive cell–cell junctions of epithelial cells that function with 
each other to hold epithelial sheets together. Both are connected with the cytoskeleton and 
represent sites of mechanical coupling between cells. (2) Tight junctions (zonula occludens) 
that constitute a diffusion barrier. (3) Gap junctions, where intercellular channels allowing for 
the direct exchange of small molecules between cells [4, 5]. While suprabasal, differentiating 
keratinocytes adhere to each other, undifferentiated basal keratinocytes are anchored to the 
dermis and interact with extracellular matrix. Basal cell surfaces not in contact with basement 
membrane have desmosomes which attach adjacent keratinocytes [1].
2. Desmosomes
Desmosomes are disc-like strong cell–cell adhesion complexes that act as anchors linking the 
intermediate filament (IF) cytoskeletons of neighboring cells in tissues that undergo large 
amounts of mechanical strain such as the heart and skin [6, 7]. In addition to their adhesive 
role, desmosomes are dynamic structures that regulate normal physiological processes such 
as proliferation and differentiation during development, tissue morphogenesis and wound 
healing [3, 6, 8–10].
Desmosomes are described as small dense nodules at the contact points between neighboring 
cells. “Desmos” means “bond” and “soma” means “body.” Electron microscopic investigations 
and newly developed procedures have supplied detailed knowledge about their structures and 
major protein components [3].
Desmosomes are 0.2–0.5 μm in diameter in human epidermis and consist of dense plaques 
located symmetrically on the plasma membranes of adjoining cells. Extracellular domain, a 
dense midline separates the membranes [8, 11].
Desmosomes, calcium-dependent junctions, have five major component proteins such as the 
desmosomal cadherins (DCs) [desmoglein (dsg) and desmocollin (dsc)], the plakin family [des-
moplakins, (DP)], and the armadillo proteins [plakoglobin (PK) and plakophilin (PP)] [6, 8].
2.1. Desmosomal cadherins
Dsg and dsc are desmosomal adhesion molecules, and there are four dsg (1–4) and three dsc 
(1–3) in different tissues in humans. Dsg2 and dsc2 are present in all tissues that contain des-
mosomes such as simple epithelia, myocardium and are present in low amounts in basal layer 
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of complex epithelia like epidermis [4, 6]. While dsg4 is present in both stratified epithelia and 
hair, dsg1/3 and dsc1/3 are found only in stratified epithelia. Dysregulation of desmosomal 
cadherins causes skin, hair, heart and digestive tract disorders and cancer because of their 
roles in epithelial morphogenesis and differentiation [6].
Extracellular domains of dsg and dsc are highly homologous to those of classical cadherin, 
E-cadherin, which have five extracellular cadherin repeats containing Ca2+ binding sites and 
a cell-adhesion recognition (CAR) site [4, 8]. The cytoplasmic domains of dsg have a mem-
brane proximal region, including an intracellular cadherin-typical region and a dsg-specific 
region [8].
Dsg 1 expression is higher in suprabasal layers in the skin epithelium. Dsg1 can support kera-
tinocyte differentiation. Extracellular regions of dsg1 do not play a role in this function; they 
are needed for adhesion. In the recent years, mutations in dsg1 that cause severe skin der-
matitis, multiple allergies and metabolic wasting syndrome (SAM) have been identified [6].
In the epidermis, dsg1 and 3 show inverse distribution patterns, dsg3 is present in high lev-
els in the basal layer but dsg1 is found in low levels in this layer. However, the upper layers 
have high levels of dsg1 and low levels of dsg3. Therefore, pemphigus foliaceus causes bullae 
only in the most superficial layers of the skin while pemphigus vulgaris leads to blisters in 
the basal layers of the skin. Because dsg1 and dsg3 are both found in the intermediate layers, 
blisters do not typically occur in these layers (compensation hypothesis) [6].
2.2. The armadillo repeat and plakin families of desmosomal plaque proteins
The armadillo-repeat family members which are PG and the PP are characterized by their 
central arm-repeat domains. PG, together with PP, provides the adhesion of DP to keratin 
intermediate filaments and mediates important signal transduction pathways and regulates 
the clustering of desmosomal components [12].
İ. Plakoglobin: PG has three structural components as an N-terminal and a C-terminal domain 
which are separated by the central 12 arm-repeat domain and is homologous to b-catenin. 
Despite this homology, PG and b-catenin are differently distributed at cell–cell contacts. 
b-catenin normally is not a component of desmosomes and is only present in adherens junc-
tions unlike PG [5]. PG plays an important role in heart, skin and hair development. Pg−/− 
mice show severe cardiac defects and Naxos disease that presents with arrhythmogenic right 
ventricular cardiomyopathy, wooly hair and keratoderma due to the mutation in the gene 
encoding PG [8].
ii. Plakophilins: PP are members of armadillo-repeat family, and PP1 was originally isolated 
as an accessory desmosomal plaque protein in stratified and complex epithelia binding to 
keratin. Later, PP2 and 3 and their subtypes were defined. PP are present both at desmosomes 
and in the nucleus [5]. While PP1 is mostly expressed in the suprabasal layer, PP2 is located 
in lower layers of stratified epithelia and heart [12]. All PP have diverse biological and patho-
logical roles [6]. PP1 has an important role in desmosomal plaque formation and stability. 
PP1 mutation causes ectodermal dysplasia-skin fragility syndrome in which skin fragility, 
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inflammation, ectodermal development abnormalities such as scant hair, hypohidrosis and 
astigmatism are seen [8]. Also, PP1 is elevated in the head and neck cancers and Ewing sar-
coma. Therefore, it has been thought that PP1 regulates cell proliferation and growth.
PP2 has a role in the regulation of actin cytoskeletal dynamics, cell migration and tumorigen-
esis in addition to modulation of intercellular adhesion. PP2 is a new positive regulator for 
EGFR activation. Knockdown of PP2 causes the attenuation of EGFR-mediated signals and 
tumor development [6].
Also, the mutations in PP2 have been identified as a cause of arrhythmogenic right ventricular 
cardiomyopathy.
PP3 mutations have not yet been identified in humans but pp3 deficient mice developed 
cutaneous inflammation and hair abnormalities [8]. This protein mRNA expression has been 
found to be significantly higher in gastrointestinal cancer patients than controls. Also, its level 
increased in advanced stages and metastatic cancer. Moreover, it was found that PP3 was 
increased in breast and pancreatic cancers [6].
2.3. The desmosomal plakin family proteins
Plakins presents with a family of very large cytolinker proteins of 200–700 kDa. They have 
important role in the cross-linking of actin microfilaments, microtubules and/or intermediate 
filaments to each other and provide the connection of adhesive junctions with the cytoskel-
eton. There are seven identified plakin proteins and four of them, desmoplakin (DP), plektin, 
envoplakin and periplakin are localized in the desmosomes [5].
i. Desmoplakin: DP is an essential desmosomal component in the connection of desmosomal 
proteins with intermediate filament (IF) cytoskeleton. DP has a critical role in the heart and 
skin. Global knockout of DP in mouse causes lethality at embryonic days leading to a dra-
matic decrease in the desmosome numbers [6].
The N-terminal plakin domain peptide (DP-NTP) is essential to target DP to desmosomal 
plaques and contains binding sites for PPs and PG. The carboxy terminal domain of DP is 
composed of three plakin repeat domains (PRDs) named A, B and C and is responsible for 
the attachment of IF [5, 12]. The molecular interactions within the desmosomal plaque pro-
tein network are much complicated. It has been shown that the PP1 head domain acts as 
a lateral linker and allows the recruitment of additional DP molecules to the desmosomal 
plaque. Moreover, there is evidence that DP might bind directly to desmosomal cadherins in 
the absence of PG and PPs. But, in cells expressing PP1 and PG, DP preferentially binds to 
PP1. While dsg1 is the only desmosomal cadherin that interacts with the PP1 head domain 
PP2 interacts directly with dsg1 and 2, and dsc1a and 2a. In contrast to PP1, PP2 binds to 
PG. Together with the different tissue distribution of the PPs, the different binding specifici-
ties may be involved in the regulation of the size and cadherin composition of desmosomes 
and the efficiency of IF binding to desmosomes [5].
Two major isoforms of DP were identified: DP1 and DP2. Both are widely expressed in numer-
ous tissues but DP2 is absent/reduced in the heart and simple epithelia [12]. The loss of DP2 
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causes a more severe adhesion defect due to mechanical stress [6]. DP2 has a more significant 
role than DP1 in maintaining the adhesion of keratinocytes [12]. Sarcoendoplasmic reticulum 
Ca+2-ATPase isoform 2 (SERCA2) regulates DP translocation to sites of cell–cell adhesion 
and SERCA2 is often mutated in Darier’s disease. If mutation in DP leads to complete loss 
of protein or loss of the IF-binding C terminus, it results in lethal acantholytic epidermolysis 
bullosa with or without apparent associated cardiomyopathy. DP missense mutation can lead 
to Carvajal/Naxos syndrome that is characterized by keratoderma, wooly hair and cardiomy-
opathy [6, 8]. Consequently, desmosome mutations can lead to aberrant gap junctions and 
abnormal heart and epidermal functions, abnormal barrier homeostasis of skin. The loss of 
DP may also be associated with some cancers and/or their local invasion because of the loss 
of desmosomal function [6].
ii. Plectin: Plectin, a huge protein, was an originally IF-binding protein and was identified in 
hemidesmosomal and focal adhesion structures in the basal membrane of keratinocytes in 
the basal layer of the skin and striated, smooth and cardiac muscles. Later, it was shown that 
plectin is also expressed in desmosomes. However, it has an auxiliary role and is not a major 
component of desmosomes. It has major function in the organization of microtubules, actin 
and IF by coordinated cross-linking and the regulation of their dynamics. Plectin gene muta-
tion does not cause blistering in the epidermis but cause blister formation in the epidermal 
basal layer by affecting hemidesmosomes. Plectin gene mutation causes autosomal recessive 
epidermolysis bullosa simplex (EBS) associated with muscular dystrophy [5].
iii. Envoplakin: Envoplakin was originally identified as a plakin protein family member. It 
was found along IFs and is partially colocalized with DP at desmosomes in terminally dif-
ferentiating keratinocytes. Similar to plectin, envoplakin is not a major component of des-
mosomes. Envoplakin knockout mice normally develop but they have only a slight delay 
in barrier acquisition. No disorders due to the envoplakin mutations have been defined in 
humans yet [5].
iv. Periplakin: Similar to envoplakin, periplakin is upregulated during terminal differentiation 
of keratinocytes in cornified envelope. It is distributed more extensively than envoplakin, but 
there is little knowledge about its role in other tissues. Plectin, envoplakin and periplakin play 
a role as auxiliary factors in strengthening IF attachment to desmosomes at the desmosomal 
plaque [5].
2.3.1. The specificity of desmosomal adhesion
Data have shown that adhesive binding between dsc2 and 3 and dsg2 and 3 are both homo-
philic and isoform specific. Dsg3 can mediate weak homophilic adhesion. Dsc3 shows homo-
philic binding. While there is a heterophilic interaction between dsc3 and dsg1, there is no 
interaction between dsc3 and dsg3 [8].
2.3.2. Desmosomal hyperadhesion
Hyperadhesion, a strongly adhesive state is a distinctive property of desmosomes from other 
intercellular junctions. Adoption of hyperadhesion is a property of dsc. Keratinocytes proliferate 
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in low Ca2+ medium but do not contact adjacent cells. At the early stage of desmosomal devel-
opment, desmosomal adhesion is Ca2+ −dependent, and chelating agents may induce the 
loss of adhesion and splitting of desmosomes. A rise in Ca2+ concentration induces assembly 
of AJ and desmosomes and in the late stage, epithelial desmosome becomes resistant to low 
Ca2+, and hyperadhesion is characterized by Ca2+ independence [5]. Hyperadhesion is asso-
ciated with the ordered arrangement of the dsc. Phosphokinase (PK) Ca may regulate Ca2+ 
dependence and inhibit hyperadhesion. Phosphorylation of desmosomal plaque components 
or different cytoplasmic signals may cause rearrangement in the plaque and transmit a signal 
to EC domains [8].
2.3.3. Desmosome assembly
The cell–cell contact and specific adhesive interaction are essential components for desmo-
some assembly. Any disorders of these components caused by low extracellular Ca2+, anti-
bodies and blocking peptide inhibit desmosomal assembly. It was shown that intercellular 
adhesion starts in AJ and then stabilized by desmosomes. Antibodies to E and P cadherin 
block AJ and also inhibit desmosome formation [5]. PG plays an essential role in desmosomal 
assembly by providing interaction between AJ and desmosomes (cross-talk). Other compo-
nents of desmosomal assembly are PP, dsc, dsg and DP [5, 8]. However, desmosomal assembly 
can also be induced by protein kinase C signaling in case of lacking of AJ. In the first step, dsg3 
is transported to the cell surface, and in the second step, IF attached and half-desmosome-like 
structures are developed and they intermediate desmosome formation. If half desmosomes 
are not finally stabilized by interactions with half desmosomes on the adjacent cells they 
undergo endocytosis and degrade [5].
3. Desmosomes in diseases
The role of desmosomes in maintaining tissue integrity is defined by the large number of 
diseases in which one or more of its constituents are impaired [4]. The impairment of adhe-
sive functions of desmosomal cadherins results from either development of autoantibodies 
against desmosomal cadherins or by gene mutations. Pemphigus is a family of blistering skin 
disorders caused by autoantibodies against desmosomal cadherins [5].
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are two most common forms of pem-
phigus family and potentially fatal disorders characterized by blister formation in skin and 
mucous membranes (in PV) due to the acantholysis, loss of keratinocytes cell–cell adhesion. 
Immunochemical studies showed that in PV, autoantibodies are immunoglobulin (Ig) G type 
and are directed against dsg3, 130 kD glycoprotein, or both dsg3 and dsg1, 160 kD antigen 
[5, 13], while in PF, they directed to only dsg1 [1, 12–14]. IgG1 and 4 type autoantibodies are 
indicators for active disorder while IgG2 is found in remission [1, 3]. Dsg3 and dsg1 show 
different expression patterns throughout epidermis. Dsg1 is expressed throughout epidermis 
and oral mucosa but it is more predominant in superficial epidermis than in deep epidermis. 
In contrast, dsg3 is expressed throughout the oral mucosa but it is only present in basal and 
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lower epidermal cells. In PF, anti-dsg IgG antibodies cause blistering in the superficial epi-
dermis, but not in the mucosa or deep epidermis because dsg3 expression compensates loss 
of function due to the anti-dsg1 antibodies. In PV, anti-dsg3 antibodies cause blister develop-
ment in the deepest layer of mucosa, where dsg1 expression is minimal. Mucocutaneous type 
PV results from both anti-dsg1 and anti-dsg3 antibodies [14–16]. But, in this type, diffuse 
intercellular blisters throughout epidermis do not occur. A cause of it may be that cell–cell 
adhesion might be weaker at the basal and intermediate suprabasal layers, where there are 
fewer desmosomes. Another reason may be that the lower layer of epidermis might have 
better access for autoantibodies which penetrate from the dermis. The main postulate of this 
monopathogenic theory (compensation theory) is that anti-dsg3 and 1 antibodies-dependent 
disabling of cell–cell adhesion is adequate to cause detachment of keratinocytes and form the 
blisters [3, 17]. However, data demonstrated that inactivation of dsg3 gene or depletion of 
dsg3 from keratinocytes could not induce gross blistering in the skin. In striate palmoplantar 
keratoderma which is due to N-terminal deletion of dsg1 acantholysis or skin blisters are 
not seen. Thus, compensation theory is still controversial [3, 15, 18]. Multipathogenic theory 
works to explain blister formation by multiple hit hypothesis. According to this hypothesis, 
a simultaneous and synchronized inactivation of physiological mechanisms of cell–cell adhe-
sion causes disruption of epidermal detachment. Non-dsg antibodies may be pathogenic 
because they cause cell shrinkage, loss of adhesion at keratinocytes and/or proapoptotic sig-
naling [17]. Additionally, IgA and IgE classes of Anti-dsg3 antibodies have been found in the 
sera of PV patients [3].
T-helper cells have critical role in the formation of pemphigus autoantibodies. Activation of 
autoreactive T cells (losing self-tolerance to dsg) responsive to pemphigus antigens lead to 
induction of IgG antibodies from B cells [3, 19]. Autoimmunity to certain epitopes of dsg3, 
dsg-reactive T and B cells may be seen in normal individuals particularly, the relatives of 
PV patients. There are dsg3 reactive Th1 cells in healthy relatives but there are Th2 cells in 
PV patients. Th2 reactive cells are detected at similar frequencies in the acute, chronic active 
and remittent phases of the disease but Th1 cells are increased in chronic active PV. It was 
demonstrated that Treg cells were decreased in the serum of PV patients [3, 18]. However, 
there is no decrease in Treg cells in PV skin lesions because Treg cells accumulate in the skin 
lesions and the draining lymph nodes. It has been thought that pemphigus autoimmunity 
can be triggered by Toll-like receptors (TLR) because of the activation of PF by TLR7 agonist, 
imiquimod [3].
4. Mechanism of acantholysis
It was shown that the number and size of desmogleins are reduced in PV and PF [19]. Data 
demonstrated that pemphigus autoantibodies bind to conformational epitopes formed by the 
N-terminal 161 amino acids and stabilized by calcium on desmogleins, and that these bind-
ing areas are responsible for the pathogenicity but C-terminal extracellular domain is not the 
pathogenic domain [14]. Previous data showed that PV IgG most likely directly cause the loss 
of adhesion via the disruption of desmogleins by steric hindrance (cis or trans interaction) 
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[12, 13, 18]. Interestingly, the detachment of keratinocytes from each other first occurs in the 
interdesmosomal area, and desmosomal detachment is seen in late acantholysis. Recent stud-
ies have demonstrated that the loss of desmosomal function is not only related to the steric 
hindrance, it may be related with other mechanisms [5, 13]. PV IgG bound to unassembled 
desmosomal cadherins does not prevent desmosomal generation rather, it causes internaliza-
tion and degradation of IgG-antigen complex [15].
It has been shown that polyclonal PV IgG causes the retraction of keratin IF and intercellular 
detachment in vitro in keratinocytes obtained from wild type mice. But PG has critical impor-
tance for keratin retraction and detachment of cells [14]. PV IgG binding results in the deple-
tion of dsg3 from keratinocytes and is followed by its internalization and degradation and 
depriving the not yet assembled desmosome of dsg3 [12, 14]. This suggestion was supported 
by the demonstration of a reduction in dsg3 levels in cell lysates. In contrast, some studies 
showed that dsg3 levels increase in cell lysates due to the reduction of anchorage of dsg3 to 
the cytoskeleton caused PV IgG antibodies [15]. Recent studies in mice have not shown the 
loss of dsg3 in split desmosomes or keratin retraction in acantholytic areas and that dsg3 is 
not depleted from desmosome before acantholysis [14].
Early studies showed that non-lysosomal proteases like plasminogen activator released by 
antibody binding caused the development of blisters but later, investigations in mice did not 
support this hypothesis and demonstrated that plasmin and plasminogen activators were not 
necessary for IgG-mediated acantholysis in mice in PV. Recent studies in vivo and in vitro 
have shown that selective proteases such as MMPs disrupt the adhesion of keratinocytes lead-
ing to proteolysis of adhesion molecules. While dsg3 is digested by MMP-9, a member of 
MMPs family, cell adhesion molecules like dsg1 and E-cadherin are digested by members of 
ADAM family of MMP during apoptosis [15]. In cultured keratinocytes, it has been shown 
that PV IgG induces apoptosis resulting in acantholysis. Apoptotic keratinocytes, reduced 
antiapoptotic factors and increased proapoptotic factors were detected in the epidermis in 
PF. Thus, induction of apoptosis may be a primary factor responsible for acantholysis and loss 
of intercellular adhesion. Caspases, apoptosis enzymes that have a role in acantholysis, are 
the other proteases. It was shown that activated caspase 3 was found in the epidermis before 
the blister formation, and it could cleave desmosomal proteins such as dsg1, dgs2 and dsg3. 
Caspases also cause the disruption of plaque proteins such as PP and DP1 and DP2, plektin 
and periplakin [8, 15]. Moreover, caspase inhibitors may block blister formation [8]. Shortly, 
these data suggested that caspases have fundamental role in apoptolysis [15]. FasL and CytC 
activate both extrinsic and intrinsic apoptotic signaling pathways in keratinocytes treated 
with PV IgGs [17]. Tumor necrosis factor alpha receptor superfamily member 5 and NADAH 
dehydrogenase-like protein are involved in the extrinsic and intrinsic apoptotic pathways, 
respectively [3].
Acantholysis is an active and complex process. Interaction of cell and PV IgG causes activa-
tion of phosphatidylcholine-specific phospholipase C, an increase in inositol 1,4,5 triphos-
phate (IP3) and diacylglycerol production and protein kinase C (PKC) activity. It also causes 
an increase in intracellular calcium concentration [15]. It has been shown that PV IgG causes 
serine-phosphorylation of dsg3, and the phosphorylation leads to the loss of PG binding. Data 
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suggested that PG, a cytoplasmic plaque constituent, plays a critical role in keratin retrac-
tion because PG binding is essential for targeting dsg3 to desmosomes [8, 14]. Recently, a 
lot of protein kinase and signaling molecules, including p38 MAPK, PKC, c-myc, Src, Rho 
A, PERK, FAK, Akt/mTOR, and cdk2 have been demonstrated [11, 15]. For example, it was 
shown that p38 phosphorylation facilitates the retraction of IF and detachment of the cells 
[13]. Desmocollin genes encoded N-glycosylated type 1 transmembrane proteins belong to 
Ca-dependent cell adhesion molecules of cadherin family. Similar to dsg3, dsc3 is expressed in 
the basal and suprabasal layers of the epidermis. It was demonstrated that anti-dsc3 antibod-
ies might induce the loss of adhesion of epidermal cells and contribute to blister development 
in pemphigus. In addition to dsg and dsc3 antibodies, reactivity to dsc1, several muscarinic 
and nicotinic acetylcholine receptor subtypes, HLA molecules, a number of mitochondrial 
proteins, thyroid peroxidase and hSPCA1 encoded ATP2C1 gene were shown. Moreover, 
anti-non-dsg antibodies may show the synergistic effects with anti-dsg antibodies, in other 
words, they may potentially amplify the activity of anti-dsg antibodies [17].
Anti-mitochondrial antibodies (AMA) target the mitochondrial nicotinic acetylcholine recep-
tors that prevent apoptolysis in keratinocytes. AMA with anti-dsg antibodies can induce acan-
tholysis, AMA/anti-dsg1 induces subcorneal splitting and AMA/anti-dsg3 induces suprabasal 
acantholysis. Recent studies showed that FcRn receptors exist on the keratinocytes and are a 
single target for PV IgG. PVIgG/FcRn complexes become internalized and are transmitted to 
mitochondria. Mitochondria are damaged via AMA and apoptotic signals are triggered for 
cell shrinkage. This shrinkage resulting in cytoskeleton collapse is an outcome of energy fail-
ure due to the damaged mitochondria [17].
According to a recent hypothesis, anti-dsg antibodies are not the reason but the result because 
reactivity to dsg1/3 develops in both extracellular and intracellular domains, and this gives 
rise to the thought that dsg molecules are released to intercellular space from damaged kerati-
nocytes and become available to antigen presenting cells [3]. Consequently, pemphigus auto-
immunity is directed to multiple organ-specific and non-organ-specific proteins.
Paraneoplastic pemphigus (PNP) is a rare and serious form of pemphigus. It is different from 
other OBD because it can affect multiple organs as well as skin [11, 20]. It has unusual clini-
cal features, including severe mucosal involvement, bronchiolitis and a wide range of skin 
rash (pemphigus-like, bullous pemphigoid-like, erythema multiforme-like, graft versus host 
disease-like and lichen planus-like) [21]. It also shows unusual histopathological and immu-
nological findings. PNP lesions are extremely painful and may be localized on the palm and 
soles, conjunctiva and simple squamous epithelia. The lesions are resistant to therapy. PNP is 
usually associated with malignancies such as lymphoma and leukemia. The mortality rate of 
PNP is high (90%) [11]. It may also be associated with myasthenia gravis and thymomas [22]. 
Because of cutaneous and noncutaneous pathologies associated with neoplasia it is called as 
paraneoplastic autoimmune multiorgan syndrome [21].
In PNP, targets of autoantibodies are more than one: dsgs, dscs, DP1 and 2, bullous pem-
phigoid antigen (BPAg)1, PF, PP, envoplakin, plectin, epiplakin and alpha-2-macroglobu-
lin-like-1 (A2ML-1) that is a broad range protease inhibitor expressed stratified epithelia 
and other damaged tissues in PNP [11, 20, 22]. Characteristic autoantibodies in PNP target 
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the plakin family proteins that are molecules localized in the intracellular plaque of des-
mosomes and hemidesmosomes [20]. Also, anti-acetylcholine receptor autoantibodies and 
acetylcholinesterase autoantibodies were detected in 35 and 28% of PNP patients, respec-
tively. High levels of these autoantibodies correlated with dyspnea in PNP patients. These 
antibodies target not only epidermal proteins but also other antigens in neural and bron-
chial tissues [22].
It is currently unclear why there are multiple autoantibodies in PNP. In patients associ-
ated with thymoma, it has been thought that defective thymocyte maturation might lead 
to the production of autoreactive T cells that can induce B-cell proliferation and autoanti-
body production. In hematologic malign tumors, aberrant immunological conditions caused 
by tumors might cause the production of many autoantibodies [22]. Another theory is that 
autoantibodies against the neoplastic antigens cross-react to epithelial antigens [21]. In PNP, 
responsible immunity is not solely humoral immunity, also cellular immunity plays a role 
in the pathogenesis. Therefore, histopathology shows individual keratinocyte necrosis with 
lymphocyte exocytosis in addition to deposits of autoantibodies in direct immunofluores-
cence (DIF) examination [20].
Lymphoid tumors may produce antibodies to desmosome and hemidesmosome components. 
But this solely cannot be explained with the pathogenesis of PNP. It is thought that tumors 
may express proteins that cross-react with epithelial proteins such as plakins. Another mecha-
nism is dysregulated cytokine production by the tumor cells. The levels of interleukin (IL)-6 
which promotes B-cell differentiation and Ig production is increased in PNP. Epitope spread-
ing may explain antibodies against multiple proteins found in PNP [20].
In PNP, accumulation of activated CD8+ T cells and increased interferon gamma and tumor 
necrosis factor alpha levels were shown in the epidermis locally. Also, natural killer cells were 
detected in the affected tissues. Consequently, both humoral and cellular immunity play a 
role in the development of PNP [20].
Another subtype of pemphigus is IgA pemphigus characterized by IgA antibodies to 
desmosomal and non-desmosomal keratinocyte cell surface constituents. It has two sub-
types: subcorneal pustular dermatosis type in which there are antibodies to dsc1 and very 
rarely to dsc 2 and 3, and intraepidermal neutrophilic type in which target antigen is still 
unknown but in rare cases, anti-dsg1 and 3 antibodies are the target antigens [11, 21, 23]. 
The mechanism of the development of skin lesions is not clear. It is thought that IgA anti-
bodies might bind to the Fc receptor CD89 on monocytes and granulocytes resulting neu-
trophil chemotaxis and subsequent proteolytic cleavage of keratinocyte cell–cell junction 
[21]. Recently, IgG/IgA pemphigus which is an overlapping variant of classic IgG pem-
phigus and IgA pemphigus has been defined. Histopathological findings are acantholysis, 
blister formation localized on subcorneal or entire layer of epidermis and neutrophilic 
infiltration [11].
Pemphigus herpetiformis (PH) is a pemphigus form clinically resembling dermatitis her-
petiformis and histopathologically pemphigus. In PH, autoantibodies against dsg1, dsg3, 
both dsg1 and dsg3 and more recently, dsc1, dsc3 and an unknown 178-kDa protein were 
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 recognized. PH autoantibodies may recognize functionally less important epitopes of dsg1 
or 3; therefore, it does not lead acantholysis directly. It is thought that autoantibodies cause 
the attraction of the inflammatory cells to tissue inducing by signaling pathway of cytokine 
production by keratinocytes [21] (Table 1).
5. Basement membrane zone
Basement membranes are highly specialized forms of extracellular matrix composed of a 
distinct set of glycoproteins and proteoglycans [24]. They underlie all epithelia and endo-
thelia, enveloping nerves, muscle fibers, distinct cell compartments and whole organs [24]. 
Basement membranes of various tissues differ ultrastructurally, biochemically and function-
ally. They act as substrates for attachment of cells, templates for tissue repair, matrices for cell 
migration, substratum to influence differentiation, morphogenesis and apoptosis of epithelial 
cell layers and permeability barriers for cells and macromolecules [25]. Basement membranes 
consist of lamina densa, a central electron-dense region, adjacent to a less dense area which is 
lamina lucida or lamina rara [24].
Human skin is the body’s largest organ, which provides mechanical and immunological 
barrier against the external environment [26]. The interface between the lower part of the 
epidermis and the top layer of dermis is the dermoepidermal basement zone (BMZ) which 
maintains the structure and integrity of the skin by anchoring the overlying epidermis to the 
dermal matrix below [27]. The importance of the correct assembly of the components of BMZ 
for skin integrity is apparent from the multiple skin blistering disorders caused by muta-
tions in genes coding for proteins associated with the epidermal BMZ and from autoimmune 
Pemphigus form Target antigens
PV dsg3 or dsg3 and 1, dsc1, muscarinic and, nicotinic
acetylcholine receptor, several HLA molecules, hSPCA
mitochondrial proteins, thyroid peroxidase
subtypes
PF dsg1
PH dsg1, dsg3, dsc 1, dsc3, unknown 178-kDa protein
PNP dsgs, dscs, DP1 and 2, BPAg1, PF, PP, envoplakin,
plectin, epiplakin and A2ML-1
IgA pemphigus
SCP mostly dsc1 rarely dsc2,dsc3
IEN mostly unknown, some dsg1, dsg3
Table 1. Pemphigus forms and target antigens.
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disorders where autoantibodies target these molecules. These proteins are also important in 
tissue homeostasis, repair and regeneration [28].
The epidermal BMZ can be divided into four zones. The first zone contains the cytoskeleton, 
hemidesmosomes and plasma membranes of basal keratinocytes. The second zone is lamina 
lucida which contains filaments connecting hemidesmosomes in basal keratinocytes to the lam-
ina densa. The third zone is lamina densa and the fourth zone is sublamina densa region which 
contains anchoring fibrils, anchoring plaques and fibrillin containing microfibrils [25, 29]. The 
biochemical components of BMZ are synthesized by basal keratinocytes and dermal fibroblasts 
[30]. Molecular components of epidermal BMZ are shown in Table 2.
The basal keratinocytes are anchored to the basal lamina via the keratin intermediate fila-
ments and hemidesmosomes. The molecules within the basal lamina connect the basal kera-
tinocyte to the basal lamina which anchors the BMZ to the underlying collagenous matrix 
of the superficial dermis [31]. Hemidesmosomes are small, regularly spaced electron dense 
structures on the inner surface of the basal pole of the keratinocytes [32]. They extend from 
the intracellular compartment of basal keratinocytes to the lamina lucida in the upper portion 
of the dermal epidermal basement membrane. The intracellular domains within the basal 
keratinocytes attach to the keratin intermediate filament network, and within the lamina 
lucida, they are contiguous with anchoring filaments [30]. The anchoring filaments transverse 
the lamina lucida and insert it into the lamina densa. Beneath the lamina densa, the anchoring 
fibrils extend beneath the basement membrane within the papillary dermis. The hemidesmo-
somes, anchoring fibrils and anchoring filaments form the hemidesmosome-anchoring fila-
ment complex [25, 32]. The hemidesmosome-anchoring filament complex forms a continuous 
link between the basal keratinocyte intermediate keratin filaments and the underlying BMZ 
and dermal components [32, 33].
5.1. Molecular components of epidermal basal membrane zone
5.1.1. Cytoskeleton of basal keratinocytes
5.1.1.1. Keratin 5 and 14
There is a structural framework known as the cytoskeleton within each basal keratinocyte 
which is composed of three main types of filaments: microfilaments, microtubules and inter-
mediate filaments [31]. Basal keratinocytes express intermediate filament keratins 5 and 14 
which are the major keratins in the adult epidermis [32]. Intermediate filaments form an 
intracellular cytoskeletal network throughout the epidermis and help to maintain the cell 
shape and epithelial structural integrity both through the formation of a cell scaffold and 
through their connection to desmosomes and hemidesmosomes [27, 32]. Mutations in genes 
coding K5 and K14 interfere with the assembly of the tonofilament cytoskeleton and connec-
tion of intermediate filaments to desmosomes and hemidesmosomes [27]. Autosomal domi-
nant mutations in K5 and K14 underlie epidermolysis bullosa simplex (EBS) localized to 
hands and feet [26].
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Cytoskeleton of basal keratinocytes
Keratin 5
Keratin 14
Hemidesmosome-anchoring filament complexes
Plectin
230 kDa bullous pemphigoid antigen (BP230/BPAG1)
Type XVII collagen (180 kDa bullous pemphigoid antigen/BP AG2)
α6 ß
4
 integrin
Tetraspan CD151
Laminin 332
Type XIII collagen
Syndecans 1 and 4
α3 ß
1
 integrin
Lamina densa
Laminin 332 (formerly laminin 5)
Laminin 311 (formerly laminin 6)
Laminin 511(formerly laminin 10)
Nidogen
Type 4 collagen
BM-40/SPARC
Perlecan
Sublamina densa region
Type VII collagen
Type IV collagen
Elastin
Fibulins
Fibrillins
Latent TGF-ß-binding proteins
Linkin
Type III collagen
Type I collagen
Table 2. Molecular components of epidermal BMZ.
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5.1.2. Hemidesmosome-anchoring filament complexes
5.1.2.1. Plectin
Plectin is an epidermal plakin protein and is a component of hemidesmosome [34]. In the epi-
dermis, the N-terminal of plectin includes binding sites for the cytoplasmic region of integrin 
ß4, BP180 and actin filaments and the C-terminal connects to keratin filaments [27]. It plays a 
key role in linking the keratin filament network to hemidesmosomes at the plasma cell mem-
brane [34]. Mutations in plectin gene lead to various forms of EBS, including EBS associated 
with muscular dystrophy or with pyloric atresia and EBS-Ogna [27].
5.1.2.2. 230 kDa bullous pemphigoid antigen (BP230/BPAG1e)
The first specific target antigen of circulating autoantibodies identified in bullous pemphi-
goid patients, 230 kDa bullous pemphigoid antigen, which is also called the bullous pemphi-
goid antigen (BPAG) 1 isoform e (BPAG1e) is an intracellular, hemidesmosomal protein and 
a member of plakin family [33].
It is the major component of the hemidesmosomal inner dense plaque [29]. BPAG1e interacts 
with cytoplasmic domain of type XVII collagen, keratin intermediate filaments, erbin and 
integrin ß4. It links the keratin intermediate cytoskeleton to multiple hemidesmosome com-
ponents [32]. The N-terminal of BP230 has a role in the integration of BP230 into the desmo-
somes and has binding sites for BP180 and ß4 integrin, and the C-terminal has binding sites 
for intermediate keratin filaments [27].
Though BP230 is a major target antigen in BP, the pathogenic relevance of BP230 in BP is not 
clear due to its intracellular localization [35]. In a study in 1995 in BPAG1e knockout mice, 
hemidesmosomes were otherwise normal, but they lacked the inner plate and had no cyto-
skeleton attached. The cell growth or substratum adhesion was also not affected indicating 
that BPAG1e was not absolutely essential for hemidesmosome or BMZ assembly. The mice 
also developed severe dystonia and sensory nerve degeneration [36]. In 2014, Feldrihan et al. 
demonstrated that antibodies against BP230 were nonpathogenic in experimental models of 
bullous pemphigoid [37].
5.1.2.3. Type XVII collagen (180 kDa bullous pemphigoid antigen/BP AG2)
Type VII collagen, which is also known as 180-kDa bullous pemphigoid antigen, is a trans-
membrane collagenous protein which is located within the hemidesmosome and lamina 
lucida [26, 30]. Its intracellular ligands are plectin, BPAG1e and ß4 integrin, and the extra-
cellular ligands are α6 integrin and laminin 332 [29]. Collagen XVII spans almost the entire 
length of the BMZ and it is a major component of the hemidesmosome [31]. It is thought to 
play a role in the structure or stability of anchoring filaments, and it has an important function 
in maintaining the integrity of dermoepidermal junction [32].
Autoantibodies from patients with BP, pemphigoid gestationis (PG) and linear IgA bul-
lous disease (LABD) target the NC16a domain of BPAG2 and from patients with mucous 
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 membrane pemphigoid (MMP) tend to target the distal carboxy terminus of BPAG2, which 
extends deeper into basement membrane as well as NC16A [25].
The ectodomain of BP180 can be proteolytically shed from the cell surface through cleavage 
within the NC16A domain generating neoepitopes and the resulting 120 kDa fragment is 
LAD-1 that can be further processed into a 97 kDa fragment, which is targeted in linear IgA 
disease and also in BP and pemphigoid gestationis [35].
Mutations in COL17A1 gene encoding type VII collagen cause non-Herlitz subtypes of junc-
tional EB [27].
5.1.2.4. α6β4 integrin
Integrins are a family of cell adhesion receptors, which have important roles in ligand bind-
ing and signaling [11]. The primary integrin in the cutaneous BMZ is α6β
4
 integrin, which 
is critical in the adhesion of basal cells to the underlying BMZ [30]. It links the intracellular 
hemidesmosomal plaque to the extracellular matrix and plays an important role in initiating 
signaling pathways involved in cell migration, differentiation and survival. The large intracel-
lular domain of β
4
 integrin interacts with cytoplasmic domain of BP180 and provides linkage 
to keratin filaments via plectin. The extracellular domain of α6 and β
4
 integrins provides bind-
ing sites for various laminin isoforms, including laminin 332 [27]. Mutations in either α6 or β
4
 
chains result in autosomal recessive junctional EB associated with pyloric atresia [31].
Autoantibodies against α6 and β
4
 integrins have been detected in a subgroup of patients with 
MMP. Autoantibodies recognizing the α6 subunit were found in patients with oral lesions, 
and autoantibodies recognizing the ß4 subunit were found in patients with ocular involve-
ment [35].
5.1.2.5. Tetraspan CD151
CD151 is a member of the tetraspanin family of cell surface proteins [28]. It is expressed on the 
basolateral surface of basal keratinocytes concentrated within desmosomes [27, 28]. The pos-
sible interaction partners of CD151 are the α3β1 and α6β1 integrins [32]. CD151 is thought to 
play a role in the organization and stability of hemidesmosomes by facilitating the formation 
of stable laminin-binding complexes with integrin α6β4 as well as being involved in cellular 
signaling [27, 28].
5.1.2.6. Laminins
Laminins are a heterogeneous family of noncollagenous glycoproteins within the lamina 
lucida/lamina densa of all basement membranes. The laminin molecule is formed by three dif-
ferent polypeptide subunits: α, β and γ [38]. Laminins have a cruciform structure containing 
both globular- and rod-like segments which are implicated in interactions with other extracel-
lular matrix molecules, like the hemidesmosomal components and type VII collagen, as well 
as in cell attachment [30]. Laminins are the major components of all the basement membranes 
along with collagen IV and exist in several isoforms which have been shown to self-assemble 
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into independent networks that are cross-linked by nidogen and perlecan [38]. To date, 16 
laminin isoforms have been identified, and some of the laminin isoforms are expressed in the 
epidermal BMZ [30, 32]. Laminins 5,6 and 10 are the main epidermal BMZ-specific laminins 
[32]. Laminins promote basement membrane assembly and maintain cell and tissue integrity. 
Laminins within basement membranes serve as ligands for overlying cell surface receptors, 
thereby providing signals regarding the epithelial microenvironment [25]. The integrins, a 
family of cellular receptors, are major receptors that mediate cell adhesion to laminins [38].
Previously known as laminin 5, laminin 332 (epiligrin, kalinin, nicein, GB3 antigen, BM600) 
is the major laminin within the cutaneous BMZ [25, 30]. It consists of α3, ß3 and γ 2 laminin 
polypeptide chains [26]. It is found at the upper lamina densa/lamina lucida border at the 
base of anchoring filaments [32]. It plays an essential role in dermal-epidermal attachment 
and can be regarded as a bridge between hemidesmosomal proteins (α6ß4 integrin and type 
XVII collagen) and the anchoring fibrils (Type VII collagen) on the dermal site [27, 35].
The mutations in LAMA3, LAMB3 and LAMC2 genes encoding laminin 332 cause Herlitz type 
of junctional EB [35].
Autoantibodies against laminin 332 mainly directed against the α3 chain and can be detected 
in 20% of patients with MMP. This subgroup is termed anti-laminin 332 MMP, and it is associ-
ated with a solid malignancy in 30% of the cases [35].
Laminin γ 1 is a component of various laminin heterotrimers, including laminin 311, 321 and 
511. It has been described as a target in anti-laminin γ1 pemphigoid, previously known as 
anti-p200 pemphigoid [35].
5.1.2.7. α3ß1 integrin
The integrin α3 subunit may dimerize with ß1 integrin in the dermoepidermal junction and 
contribute to epithelial-mesenchymal signaling [27]. Integrin α3 is a transmembrane integrin 
receptor subunit that mediates signals between the cells and their microenvironment. Muta-
tions in the gene for the integrin α3 subunit causes an autosomal recessive multiorgan disorder 
characterized with interstitial lung disease, nephrotic syndrome and junctional EB [39].
5.1.2.8. Nidogen
Nidogens (previously known as entactin) are ubiquitous BM glycoproteins [24, 25]. The pre-
dominating nidogen is nidogen-1, and nidogen-2 was discovered as second mammalian iso-
form [24]. They interact with many other BMZ molecules, in particular with laminin and 
collagen IV, and their primary function appears to be stabilizing interactions between lami-
nins and collagen IV with the lamina densa [35].
Nidogens are not required for epidermal BMZ formation because of the overlapping func-
tions of many of the BMZ components [31].
5.1.2.9. Type IV collagen
Type IV collagen is found only in basement membranes and consists of three α-chain subunits 
which can be identical or genetically distinct but structurally related [25, 31]. Collagen IV’s 
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primary role in the basement membrane is structural, as its three-dimensional lattice super-
structure forms the basal lamina [31]. It is linked to laminins 5/6/10 complex by nidogen [32]. 
Collagen IV also has been associated with angiogenesis, tissue remodeling and cancer progres-
sion. There are many genetic diseases attributed to collagen IV, including Goodpasture syn-
drome, Alport syndrome, diffuse esophageal leiomyomatosis, benign familial hematuria [25].
5.1.2.10. Heparan sulfate proteoglycans
Heparan sulfate proteoglycans are glycoproteins which are found at the cell surface and in 
the extracellular matrix, where they interact with a plethora of ligands [40]. Characteristically, 
three proteoglycans are present in vascular and epithelial basement membranes, including 
perlecan, agrin and collagen XVIII [29]. They are present within, just above and just below 
the lamina densa of the epidermal basement membrane [25]. They can interact with various 
components of lamina densa, including type IV collagen and nidogen, and they are believed 
to contribute to the overall architecture of the basement membrane as well as tissue-specific 
functions [25, 29]. Their high sulfate charge contributes to the negative charge of basement 
membranes and restricts the permeability of these matrices [25].
5.1.2.11. Type VII collagen
Type VII collagen is the major component of anchoring fibrils, and it provides mechanical 
strength by linking the basal lamina and the underlying connective tissue [35]. Anchoring 
fibrils lie beneath the basal lamina, and they are fan-like, cross-banded structures extending 
into the papillary dermis that form semicircular loops [32]. They extend from the lower part 
of the lamina densa to the upper reticular dermis [25].
Type VII collagen consists of three identical α-chains that self-organize into a triple-helical 
collagenous structure. Each triple helical domain is flanked by a noncollagenous N-terminal 
and a C-terminal [27]. It contains a large globular noncollagenous domain termed NC1 in the 
amino terminal and a smaller domain termed NC2 in the carboxy terminal [25].
A large number of type VII collagen molecules laterally aggregate to form anchoring fibrils 
in which NC1 domains bind the lamina densa at one end and either loop back into lamina 
densa or else connect to anchoring plaques in sublamina densa region [25, 30]. The anchor-
ing plaques are electron-dense structures which contain collagen IV and laminin 332 [29]. 
Specific subdomains within the NC1 domains have affinity for type I fibrillar collagen in the 
dermis and type IV collagen in the lamina densa and anchoring plaques. It also interacts with 
laminin 332 [25].
The importance of anchoring fibrils in securing the adhesion of the dermal-epidermal base-
ment membrane to the underlying dermis is seen in mutations in COL7A1 encoding type VII 
collagen which underlie both autosomal dominant and autosomal recessive forms of dystro-
phic EB in which the blister formation occurs in the sublamina densa region [34].
IgG autoantibodies directed against type VII collagen also results in epidermolysis bullosa 
acquisita which is a severe, acquired autoimmune bullous disease [41].
Type VII collagen has also been described as autoantigen in a small subgroup of patients with 
MMP, bullous systemic lupus erythematosus and LABD [35] (Table 3).
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